About this item:

828 Views | 1,121 Downloads

Author Notes:

Corresponding authors at: Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Raemistrasse 100, 8091 Zurich, Switzerland. E-mail addresses: duo.li@usz.ch (D. Li), Roberto.speck@usz.ch (R.F. Speck).

DL designed, conducted and analyzed all experiments.

ES, AA, M-A.R, SI, C-N.K, BK, O-T.K assisted in some experiment.

DL, AA and RS wrote the paper.

We thank D. Boden (Tibotec, Belgium) for providing pLen-EF1α-GFP and the NIH AIDS Reagent Program for providing Raltegravir (Cat # 11680; from Merck & Company).

We are grateful to N.R. Landau, O.T. Fackler H.M. Baldauf, V. Vongrad, Y.L. Kok and A. Scherrer for advice.

Subjects:

Research Funding:

The study was supported by the OPO-Foundation and the clinical research focus program “Human Hemato-Lymphatic Diseases” of the University of Zürich (10/2012-10/2015).

RFS is supported by the SNF (SSAJRP; IZLSZ3_149100/1).

This work was partially supported by US National Institute of Health grant GM104198 (B.K.).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Cell & Tissue Engineering
  • Biotechnology & Applied Microbiology
  • Cell Biology
  • SAMHD1
  • dNTP pools
  • Transduction
  • Hematopoietic stem and progenitor cells (HSPCs)
  • Gene engineering
  • Lentiviral vectors
  • CD4(+) T-CELLS
  • GENE-TRANSFER
  • HIV-1 RESTRICTION
  • LYMPHOID-TISSUE
  • IN-VIVO
  • INFECTION
  • EXPRESSION
  • VECTORS
  • PHOSPHORYLATION
  • MACROPHAGES

Vpx mediated degradation of SAMHD1 has only a very limited effect on lentiviral transduction rate in ex vivo cultured HSPCs

Tools:

Journal Title:

Stem Cell Research and Therapy

Volume:

Volume 15, Number 2

Publisher:

, Pages 271-280

Type of Work:

Article | Final Publisher PDF

Abstract:

Understanding how to achieve efficient transduction of hematopoietic stem and progenitor cells (HSPCs), while preserving their long-term ability to self-reproduce, is key for applying lentiviral-based gene engineering methods. SAMHD1 is an HIV-1 restriction factor in myeloid and resting CD4<sup>+</sup> T cells that interferes with reverse transcription by decreasing the nucleotide pools or by its RNase activity. Here we show that SAMHD1 is expressed at high levels in HSPCs cultured in a medium enriched with cytokines. Thus, we hypothesized that degrading SAMHD1 in HSPCs would result in more efficient lentiviral transduction rates. We used viral like particles (VLPs) containing Vpx, shRNA against SAMHD1, or provided an excess of dNTPs or dNs to study this question. Regardless of the method applied, we saw no increase in the lentiviral transduction rate. The result was different when we used viruses (HR-GFP-Vpx+) which carry Vpx and encode GFP. These viruses allow assessment of the effects of Vpx specifically in the transduced cells. Using HR-GFP-Vpx+ viruses, we observed a modest but significant increase in the transduction efficiency. These data suggest that SAMHD1 has some limited efficacy in blocking reverse transcription but the major barrier for efficient lentiviral transduction occurs before reverse transcription.

Copyright information:

© 2015 The Authors. Published by Elsevier B.V.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote